As CD44 is a receptor for hyaluronan (HA), and was identified and verified as overexpressed in GBM tissues, we explored the effects of HA-treatment on cell migration, proliferation, and cell cycle in glioma cells (U87 / U373) as well as normal human astrocytes (NHA). Here, CD44 is linked to central nervous system cancer.